Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia

NCT00741715 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1736

Enrollment

INDUSTRY

Sponsor class

Stopped AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy

Conditions

Hypercholesterolemia

Interventions

DRUG: AVE5530
DRUG: atorvastatin
DRUG: placebo

Sponsor

Sanofi